21 Code of Federal Regulations §312.34, "Treatment Use of an Investigational New Drug," 1991.
21 Code of Federal Regulations §50, "Protection of Human Subjects," 1991.
52 Federal Register 33472, "Memorandum of Understanding Between the Department of Defense and the Food and Drug Administration," September 3, 1987.
55 Federal Register 52814, "Informed Consent for Human Drugs and Biologics; Determination That Informed Consent is Not Feasible," December 21, 1990.
62 Federal Register 40996, "Accessibility to New Drugs for Use in Military and Civilian Exigencies When Traditional Human Efficacy Studies Are Not Feasible; Determination Under the Interim Rule That Informed Consent is Not Feasible for Military Exigencies; Request for Comments," July 31, 1997.
Advisory Committee on Human Radiation Experiments, The Human Radiation Experiments: Final Report of the Presidential Advisory Committee, New York, Oxford University Press, 1996.
Annas, G. J., "Changing the Consent Rules for Desert Storm," New England Journal of Medicine, No. 326, 1992, pp. 770-773.
Annas, G., and M. A. Grodin, Commentary on "Treating the Troops" by EG Howe and ED Martin, Hastings Center Report, Vol. 21, No. 2, 1991, pp. 24-27.
Annas, G., and M. A. Grodin, The Nazi Doctors and the Nuremberg Code, New York: Oxford University Press, 1992.
Caplan, A., Testimony, U.S. Senate, Committee on Veterans' Affairs, "Is Military Research Hazardous to Veterans' Health? Lessons from World War II, the Persian Gulf, and Today," Hearing, May 6, 1994.
Department of Defense, Memorandum to FDA General Counsel, "Medical Products Under IND Regulations Which Are Required or Are Under Consideration for Deployment in Support of Operation Desert Shield," August 31, 1990.
Dunn, M. A., and F. R. Sidell, "Progress in Medical Defense Against Nerve Agents," Journal of the American Medical Association, No. 262, 1989, pp. 649-652.
Edgar, H., and D. J. Rothman, "The Institutional Review Board and Beyond: Future Challenges to the Ethics of Human Experimentation," The Milbank Quarterly, Vol. 73, No. 4, 1995, pp. 489-506.
Fox, R. C., and J. P. Swazey, The Courage to Fail: A Social View of Organ Transplants and Dialysis, 2nd ed., rev., Chicago: University of Chicago Press, 1978.
Gilliat, Robert L., Memorandum for the Assistant Secretary of Defense (Health Affairs), "Applicability of Human Subject Research Restrictions to Potential Medical Treatments in Connection with Operation Desert Shield," September 14, 1990.
Howe, E. G. and E. D. Martin, "Treating the Troops," Hastings Center Report, Vol. 21, No. 2, 1991, pp. 21-24.
Informed Consent Waiver Review Group (ICWRG), Memorandum to Commissioner of Food and Drugs, re IND 23,509--Pyridostigmine Bromide 30 mg Tablets--ACTION.
Journal of the American Medical Association, Vol. 276, November 27, 1996. This issue contained seven contributions related to the Nuremberg Code.
Keeler, J. R., C. G. Hurst, M. A. Dunn, "Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions," Journal of the American Medical Association, No. 266, 1991, pp. 693-695.
Kennedy, Sen. Edward M., Remarks, Congressional Record, October 2, 1972, p. S-33154-5.
Lehman, Craig R. (Lt Col, USAF), Memorandum for Record, Proceedings of Meeting Between FDA and DOD Regarding Operation Desert Shield, Federal Register, August 30, 1990.
Levine, R. J., Commentary on "Treating the Troops" by EG Howe and ED Martin, Hastings Center Report, Vol. 21, No. 2, 1991, pp. 27-29.
Martin, E., Testimony, U.S. Senate, Committee on Veterans Affairs, Is Military Research Hazardous to Veterans' Health? Lessons from World War II, the Persian Gulf, and Today, 103rd Congress, 2nd Session, May 6, 1994, p. 124.
Mendez, Enrique, Jr., M.D., letter to David A. Kessler, M.D., regarding pentavalent botulinum toxoid, December 28, 1990a.
Mendez, Enrique, Jr., M.D., letter to David A. Kessler, M.D., regarding pyridostigmine bromide, December 28, 1990b.
Memorandum from Richard A. Merrill, February 24, 1998
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research, Office of the Secretary, Department of Health, Education, and Welfare, April 18, 1979. Also 44 Federal Register 23193, April 18, 1979.
Nuremberg Code, Journal of the American Medical Association, No. 276, 1996, p. 1691.
PAC-see Presidential Advisory Committee on Gulf War Veterans' Illnesses.
Pechura, C. M., and D. P. Rall, eds., Institute of Medicine, Veterans at Risk: The Health Effects of Mustard Gas and Lewisite, Washington, D.C.: National Academy Press, 1993.
Pendergast, M. K., Statement by Mary K. Pendergast, Deputy Commissioner and Senior Advisor to the Commissioner, Food and Drug Administration, Department of Health and Human Services, before the Presidential Advisory Committee on Gulf War Veterans Illnesses, July 29, 1997.
Persian Gulf Veterans Coordinating Board, Response to the Presidential Advisory Committee on Gulf War Veterans' Illnesses, March 7, 1997.
Presidential Advisory Committee on Gulf War Veterans' Illnesses, Transcript of January 12, 1996a.
Presidential Advisory Committee on Gulf War Veterans' Illnesses, Interim Report, February 1996b.
Presidential Advisory Committee on Gulf War Veterans' Illnesses, Final Report, December 1996c.
Rettig, R. A., L. E. Earley, and R. A. Merrill, eds., Institute of Medicine, Food and Drug Administration Advisory Committees, Washington, D.C.: National Academy Press, 1992.
Robertson, J., "Legal Implications of the Boundaries Between Biomedical Research Involving Human Subjects and the Accepted or Routine Practice of Medicine," in National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research, Appendix 16, Vol. II, Washington, D.C.: Office of the Secretary, Department of Health, Education, and Welfare, April 18, 1979.
Sabiston, D., "The Boundaries Between Biomedical Research Involving Human Subjects and the Accepted or Routine Practice of Medicine, with Particular Emphasis on Innovation in the Practice of Surgery," in National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research, Appendix 17, Vol. II, Washington, D.C.: Office of the Secretary, Department of Health, Education, and Welfare, April 18, 1979.
Scales, R.H., Jr., Certain Victory: United States Army in the Gulf War, Washington, D.C.: Office of the Chief of Staff, United States Army, 1993.
Schuchardt, E. J., "Distinguishing Between Research and Medical Practice During Operation Desert Storm, Food and Drug Law Journal, No. 49, 1994, pp. 271-289.
Sidell, Takafuji, and Franz, 1997.)
Sisson, George H., Memorandum for Record, "Meeting with FDA, Friday, 14 September 1990," 17 September 1990.
U.S. Court of Appeals for the District of Columbia Circuit. John Doe and Mary Doe, Appellees. July 16, 1991. 938 F.2d 1370; 1991 U.S. App. LEXIS 14984; 291 U.S. App. D.C. 111.
U.S. Department of Defense, Defense Science Board, Report of the Defense Science Board on Persian Gulf War Health Effects, June 1994.
U.S. Department of Defense, Protection of Human Subjects in DoD-Supported Research, DoD Directive 3216.2, January 7, 1983.
U.S. District Court for the District of Columbia. John Doe and Mary Doe, Plaintiffs, v. Louis W. Sullivan and Richard Cheney, Defendants. January 31, 1991. 756 F. Supp. 12; 1991 U.S. Dist. LEXIS 1702.
U.S. House of Representatives, Committee on Government Reform and Oversight, Subcommittee on Human Resources, Oversight of HHS: Bioethics and the Adequacy of Informed Consent, Hearing, May 8, 1997.
World Medical Association, Declaration of Helsinki, "Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects," Journal of the American Medical Association , No. 277, 1997, pp. 925-926.